Exagen market cap XGN
Share price times shares outstanding: what the whole company sells for, since 2019.
- Today, Nov 2, 2026
- $203.3M
- Highest close in our data
- $323.3M
- Dec 2019
Exagen is worth $203.3M at the close on Nov 2, 2026, at $8.39 a share.
That is down 6% over the last year and down 0% over five years.
Its highest close in our data was $323.3M in Dec 2019.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $203.3M | $64.5M | $211.2M | +46% |
| 2025 | $138.9M | $55.9M | $263.2M | +67% |
| 2024 | $83.1M | $23.6M | $101.9M | +145% |
| 2023 | $33.9M | $24.4M | $54.7M | −13% |
| 2022 | $39.2M | $36.9M | $171.3M | −79% |
| 2021 | $188M | $151.3M | $264.6M | +13% |
| 2020 | $167M | $134.2M | $309.5M | −48% |
| 2019 | $323.3M | $224.1M | $323.3M | n/a |
Against its peers
Companies in Healthcare nearest Exagen's size, closest first, today.
| Company | Market cap |
|---|---|
| XGNExagen | $203.3M |
| PLXProtalix BioTherapeutics | $206.3M |
| NATRNatures Sunshine Products | $211.5M |
| ELMDElectromed | $223.9M |
| PDEXPro DEX | $184.5M |
| UTMDUtah Medical Products | $224.6M |
| INFUInfuSystem | $275.7M |
| CYHCommunity Health Systems | $296.2M |
| EMBCEmbecta | $350.7M |
| VMDViemed Healthcare | $359.6M |
| CRMDCorMedix | $420.1M |
| Peer median | $250.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Exagen
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.